Vaccination data show that, in several states, people in wealthier counties are being vaccinated at a higher rate than people in poorer counties. According to a STAT investigation, Connecticut, California, New Jersey and Florida show the largest disparities in vaccination rates based on income. (STAT)

Tocilizumab, an arthritis drug developed by Roche, may lower the risk of death among people hospitalized with COVID-19. The drug also shows promise in curtailing the duration of patient hospital stays. (CNBC Weekly)

Novo Nordisk’s semaglutide proved effective in treating obesity in a clinical trial. Participants who received the drug lost nearly 15% of their body weight, and many saw an improvement in diabetes symptoms. (The New York Times)

Alabama registered the lowest rate of vaccine administration in the country this week, largely due to poor funding and outdated software. Many of the state’s issues are “indicative of the general erosion of the rural health-care infrastructure across the country,” Mark Holmes told the Wall Street Journal. (The Wall Street Journal)

Bristol Myers Squibb has scrapped orva-cel, its CAR-T therapy for multiple myeloma, in order to focus on other drugs in its pipeline. The company said it will concentrate on ide-cel as the “front runner.” (Endpoints News)